88 related articles for article (PubMed ID: 33000231)
1. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA NEAT1 promotes ovarian cancer cell invasion and migration by interacting with miR‑1321 and regulating tight junction protein 3 expression.
Luo M; Zhang L; Yang H; Luo K; Qing C
Mol Med Rep; 2020 Oct; 22(4):3429-3439. PubMed ID: 32945443
[TBL] [Abstract][Full Text] [Related]
3. High expression of SLC7A1 in high-grade serous ovarian cancer promotes tumor progression and is involved in MAPK/ERK pathway and EMT.
You S; Han X; Xu Y; Sui L; Song K; Yao Q
Cancer Med; 2024 May; 13(10):e7217. PubMed ID: 38752472
[TBL] [Abstract][Full Text] [Related]
4. Paeoniflorigenone inhibits ovarian cancer metastasis through targeting the MUC1/Wnt/β‑catenin pathway.
Liu Q; Jiang L; Zhao Y; Su F; Li J; Tian X; Liu W; Jiang X; Xu Y; Tao F
Int J Mol Med; 2024 Jul; 54(1):. PubMed ID: 38785138
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis.
Xie W; Zhang L; Shen J; Lai F; Han W; Liu X
BMC Cancer; 2024 May; 24(1):551. PubMed ID: 38693472
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of growth differentiation factor-15 restrains prostate cancer through regulating MAPK/ERK signaling pathway.
Yang M; Guo M; Su C; Hao W; Xu Z
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):162-167. PubMed ID: 38650142
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway.
Zeng Z; Gao ZL; Zhang ZP; Jiang HB; Yang CQ; Yang J; Xia XB
Int J Mol Med; 2019 Jul; 44(1):103-114. PubMed ID: 31115482
[TBL] [Abstract][Full Text] [Related]
8. 12-O-deacetyl-phomoxanthone A inhibits ovarian tumor growth and metastasis by downregulating PDK4.
Yang C; Xing S; Wei X; Lu J; Zhao G; Ma X; Dai Z; Liang X; Huang W; Liu Y; Jiang X; Zhu D
Biomed Pharmacother; 2024 Jun; 175():116736. PubMed ID: 38739992
[TBL] [Abstract][Full Text] [Related]
9. Interference with MTHFD2 induces ferroptosis in ovarian cancer cells through ERK signaling to suppress tumor malignant progression.
Mo X; Liu Q; Liang K; Song Y
J Bioenerg Biomembr; 2024 Jun; 56(3):333-345. PubMed ID: 38488992
[TBL] [Abstract][Full Text] [Related]
10. The Biological and Clinical Role of the Long Non-Coding RNA LOC642852 in Ovarian Carcinoma.
Filippov-Levy N; Reich R; Davidson B
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718068
[TBL] [Abstract][Full Text] [Related]
11. Psip1/p52 regulates posterior Hoxa genes through activation of lncRNA Hottip.
Pradeepa MM; McKenna F; Taylor GC; Bengani H; Grimes GR; Wood AJ; Bhatia S; Bickmore WA
PLoS Genet; 2017 Apr; 13(4):e1006677. PubMed ID: 28384324
[TBL] [Abstract][Full Text] [Related]
12. Sustained activation of the FGF1-MEK-ERK pathway inhibits proliferation, invasion and migration and enhances radiosensitivity in mouse angiosarcoma cells.
Miura T; Kado J; Ashisuke K; Masuzawa M; Nakayama F
J Radiat Res; 2024 May; 65(3):303-314. PubMed ID: 38637316
[TBL] [Abstract][Full Text] [Related]
13. LRP8 promotes tumorigenesis in ovarian cancer through inhibiting p53 signaling.
Xu Y; Zhou Y; Yi X; Nie X
Cell Biol Int; 2024 May; 48(5):626-637. PubMed ID: 38263609
[TBL] [Abstract][Full Text] [Related]
14. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
Gao Y; Hou J; Fei X; Ren L; Lu R; Liu P; Liu S; Zhu C; Wang X; Pan Y
Cell Signal; 2024 May; 120():111227. PubMed ID: 38744388
[TBL] [Abstract][Full Text] [Related]
15. LncRNA HOTTIP promotes LPS-induced lung epithelial cell injury by recruiting DNMT1 to epigenetically regulate SP-C.
Li S; Li S; Gao Z; Liu Y
J Cell Commun Signal; 2024 Mar; 18(1):e12020. PubMed ID: 38545254
[TBL] [Abstract][Full Text] [Related]
16. Isoglutaminyl Cyclase Overexpression Enhances KYSE30 Cancer Cell Proliferation and Migration via the MAPK Signaling Pathway.
Chen X; Yu X; Cui Y; Du L; Zhou Q; Xiong W; Li C; Xu C; Wu H
J Proteome Res; 2024 May; 23(5):1859-1870. PubMed ID: 38655723
[TBL] [Abstract][Full Text] [Related]
17. Functional implications of PABPC1 in the development of ovarian cancer.
Feng C; Han YH; Qi N; Li J; Sheng QH; Liu Y; Yang LL
Open Med (Wars); 2021; 16(1):805-815. PubMed ID: 34027108
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1.
Zheng ZJ; Liu Y; Wang HJ; Pang WW; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9282-9289. PubMed ID: 33015769
[TBL] [Abstract][Full Text] [Related]
19. A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer.
Wu L; Chen W; Cao Y; Chen B; He Y; Wang X
Aging (Albany NY); 2023 Jul; 15(13):6445-6466. PubMed ID: 37424068
[TBL] [Abstract][Full Text] [Related]
20. LINC01119 encapsulated by cancer-associated adipocytes-derived exosomes promotes M2 polarization of macrophages to induce immune escape in ovarian cancer in a 3D co-culture cell-based model.
Zheng Q; Zhang J; Liu Y; Dong W; Dai X; Du X; Gu D
Clin Transl Oncol; 2023 Nov; 25(11):3174-3187. PubMed ID: 37142874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
